Figure 1
Figure 1. Salidroside prevents oxidative stress–induced HSC loss. (A) salidroside partially limits H2O2-induced LSK expansion. BM cells from WT C57BL/6 mice pretreated with or without salidroside (75μg/g body weight) followed by H2O2 (0.25 μmol/g body weight) injection were harvested for LSK (Lin-Sca1+c-kit+) cell frequency assessment using flow cytometry. (B) Quantification of LSK frequency in mice described in panel A. (C) SD prevents H2O2-induced LSK CD34-Flt3- cell loss. BM cells described in panel A were subjected to clow cytometry analysis for LSK CD34−Flt3− frequency. (D). Quantification of LSK CD34−Flt3− frequency in mice described in panel A. (E) SD prevents H2O2-induced LSK CD150+CD48− cell loss. BM cells described in panel A were subjected to Flow Cytometry analysis for LSK CD150+CD48− frequency. (F) Quantification of CD150+CD48− frequency in mice described in panel A. Results are means ± standard deviation (SD) of 3 independent experiments (n = 9 per group).

Salidroside prevents oxidative stress–induced HSC loss. (A) salidroside partially limits H2O2-induced LSK expansion. BM cells from WT C57BL/6 mice pretreated with or without salidroside (75μg/g body weight) followed by H2O2 (0.25 μmol/g body weight) injection were harvested for LSK (Lin-Sca1+c-kit+) cell frequency assessment using flow cytometry. (B) Quantification of LSK frequency in mice described in panel A. (C) SD prevents H2O2-induced LSK CD34-Flt3- cell loss. BM cells described in panel A were subjected to clow cytometry analysis for LSK CD34Flt3 frequency. (D). Quantification of LSK CD34Flt3 frequency in mice described in panel A. (E) SD prevents H2O2-induced LSK CD150+CD48 cell loss. BM cells described in panel A were subjected to Flow Cytometry analysis for LSK CD150+CD48 frequency. (F) Quantification of CD150+CD48 frequency in mice described in panel A. Results are means ± standard deviation (SD) of 3 independent experiments (n = 9 per group).

Close Modal

or Create an Account

Close Modal
Close Modal